Patents by Inventor Tarun K. Ghosh

Tarun K. Ghosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene expression systems and recombinant cell lines
    Publication number: 20040197865
    Abstract: The present invention provides gene expression systems useful for detecting agonists of Toll-like receptors. The gene expression systems include a nucleic acid sequence encoding a Toll-like receptor and a second nucleic acid sequence that encodes a reporter operably linked to an expression control sequence. The recombinant cell lines include a gene expression system according to the present invention.
    Type: Application
    Filed: December 10, 2003
    Publication date: October 7, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Shalley K. Gupta, Tarun K. Ghosh, Jason R. Fink
  • Aryl substituted imidazoquinolines
    Publication number: 20040147543
    Abstract: Aryl substituted imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral, and neoplastic, are disclosed.
    Type: Application
    Filed: December 18, 2003
    Publication date: July 29, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: David S. Hays, Shri Niwas, Tushar Kshirsagar, Tarun K. Ghosh, Shalley K. Gupta, Phillip D. Heppner, Bryon A. Merrill, Jason D. Bonk, Michael E. Danielson, John F. Gerster, Chad A. Haraldson, Sarah Johannessen, Maureen A. Kavanagh, Kyle J. Lindstrom, Ryan B. Prince, Matthew R. Radmer, Michael J. Rice, David J. Squire, Sarah A. Strong, Joshua R. Wurst
  • Assays relating to Toll-like receptor activity
    Publication number: 20040132079
    Abstract: The present invention provides assays useful for detecting agonists of Toll-like receptors. The assays include, generally, providing a cell culture transfected with a nucleic acid sequence that encodes a reporter operably linked to a TLR-inducible expression control sequence; contacting the cell culture with a test compound; and identifying the compound as a TLR agonist if TLR-inducible expression of the reporter can be detected.
    Type: Application
    Filed: December 10, 2003
    Publication date: July 8, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Shalley K. Gupta, Tarun K. Ghosh, Jason R. Fink